Many individuals have been told that their illness is "treatment resistant." However, this only means that they haven't ...

A mental health professional familiar with cognitive remediation would be the best guide for group treatment. Do you live with major depressive disorder? Learn about the resources and protections ...

Depression, which doctors may call major depressive disorder, is a treatable mental ... test to see if you have it and help you manage and treat it. By far, insomnia is the most common sleep ...

Nelivaptan (NB-415, SSR-149415) is under development for the treatment of depression including major depressive disorder (MDD). The drug candidate targets vasopressin receptor 1B ( (V1bR). It is ...

The following is a summary of “Service coverage for major depressive disorder: estimated rates of minimally adequate ...

Neumora Therapeutics to release phase 3 data on Navacaprant for MDD treatment in 2024. Check out NMRA's catalysts that might ...

In past trials, ketamine intravenous treatment has shown promise, with 64% of depression patients in trials experiencing ...

Lysergic acid diethylamide is under clinical development by Mind Medicine MindMed and currently in Phase II for Major Depressive Disorder.

Vagus nerve stimulation therapy improved the symptoms of treatment-resistant depression for nearly 500 participants in a ...

He further added, "PDC-1421 is a novel compound derived from plant sources and has shown promise in treating Major Depressive ...